Charles S Grob

Title(s)Professor of Clinical , Psychiatry and Biobehavioral Sciences
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor of Clinical , Pediatrics


    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement. JAMA Netw Open. 2024 Jun 03; 7(6):e2414650. McGuire AL, Cohen IG, Sisti D, Baggott M, Celidwen Y, Devenot N, Gracias S, Grob C, Harvey I, Kious B, Marks M, Mithoefer M, Nielson E, Öngür D, Pallas A, Peterson A, Schenberg EE, Summergrad P, Waters B, Williams MT, Yaden DB. PMID: 38833254.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution. J Am Acad Child Adolesc Psychiatry. 2024 May 09. Jeffrey JK, Weintraub MJ, Grob CS. PMID: 38734406.
      View in: PubMed   Mentions:    Fields:    
    3. In Memoriam: Roland R. Griffiths (July 19, 1946-October 16, 2023). J Psychoactive Drugs. 2024 May 06; 1-2. Henningfield JE, Belouin SJ, Yaden DB, Urrutia J, Anderson BT, Berger A, Grob CS, Labate BC, Maier LJ, Maternowska MC, Weichold F, Magar V. PMID: 38706326.
      View in: PubMed   Mentions:    Fields:    
    4. Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy. Am J Psychiatry. 2024 Jan 01; 181(1):74-75. O'Donnell KC, Anderson BT, Barrett FS, Bogenschutz MP, Grob CS, Hendricks PS, Kelmendi B, Nayak SM, Nicholas CR, Paleos CA, Stauffer CS, Gukasyan N. PMID: 38161295.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. J Psychoactive Drugs. 2023 Nov-Dec; 55(5):523-538. Urrutia J, Anderson BT, Belouin SJ, Berger A, Griffiths RR, Grob CS, Henningfield JE, Labate BC, Maier LJ, Maternowska MC, Weichold F, Yaden DB, Magar V. PMID: 37747281.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. Am J Geriatr Psychiatry. 2023 01; 31(1):44-53. Johnston CB, Mangini M, Grob C, Anderson B. PMID: 36184377.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    7. Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Neuropharmacology. 2022 11 15; 219:109214. Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. PMID: 35973601; PMCID: PMC9536012.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    8. If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics. J Pain. 2022 10; 23(10):1666-1679. Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC. PMID: 35643270.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Challenges in translational research: MDMA in the laboratory versus therapeutic settings. J Psychopharmacol. 2022 Mar; 36(3):252-257. de Wit H, Bershad AK, Grob C. PMID: 33944625.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Psychedelic medicine: safety and ethical concerns. Lancet Psychiatry. 2020 10; 7(10):829-830. Anderson BT, Danforth AL, Grob CS. PMID: 32949507.
      View in: PubMed   Mentions: 23     Fields:    
    11. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology (Berl). 2018 Nov; 235(11):3137-3148. Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A. PMID: 30196397; PMCID: PMC6208958.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    12. Is LSD toxic? Forensic Sci Int. 2018 Mar; 284:141-145. Nichols DE, Grob CS. PMID: 29408722.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    13. Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Lancet Psychiatry. 2016 May; 3(5):481-8. Mithoefer MC, Grob CS, Brewerton TD. PMID: 27067625.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    14. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 04; 64:237-49. Danforth AL, Struble CM, Yazar-Klosinski B, Grob CS. PMID: 25818246.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    15. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. J Psychoactive Drugs. 2014 Jan-Mar; 46(1):73-7. Greer GR, Grob CS, Halberstadt AL. PMID: 24830188.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    16. Statement on ayahuasca. Int J Drug Policy. 2012 May; 23(3):173-5. Anderson BT, Labate BC, Meyer M, Tupper KW, Barbosa PC, Grob CS, Dawson A, McKenna D. PMID: 22459485.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    17. An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment. Psychiatr Serv. 2011 Nov; 62(11):1303-9. Asarnow JR, Baraff LJ, Berk M, Grob CS, Devich-Navarro M, Suddath R, Piacentini JC, Rotheram-Borus MJ, Cohen D, Tang L. PMID: 22211209; PMCID: PMC3251923.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    18. Hallucinogens as medicine. Sci Am. 2010 Dec; 303(6):76-9. Griffths RR, Grob CS. PMID: 21141361.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    19. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011 Jan; 68(1):71-8. Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. PMID: 20819978.
      View in: PubMed   Mentions: 284     Fields:    Translation:Humans
    20. Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attempters. J Am Acad Child Adolesc Psychiatry. 2008 Aug; 47(8):958-66. Asarnow JR, Baraff LJ, Berk M, Grob C, Devich-Navarro M, Suddath R, Piacentini J, Tang L. PMID: 18596552.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    21. A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation. J Anal Toxicol. 2006 Jul-Aug; 30(6):406-7; author reply 407. Callaway JC, Grob CS, McKenna DJ, Nichols DE, Shulgin A, Tupper KW. PMID: 16872575.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    22. Ayahuasca in adolescence: a neuropsychological assessment. J Psychoactive Drugs. 2005 Jun; 37(2):123-8. Doering-Silveira E, Lopez E, Grob CS, de Rios MD, Alonso LK, Tacla C, Shirakawa I, Bertolucci PH, Da Silveira DX. PMID: 16149323.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    23. Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J Psychoactive Drugs. 2005 Jun; 37(2):141-4. Doering-Silveira E, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, Da Silveira DX. PMID: 16149326.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    24. Ayahuasca use in cross-cultural perspective. J Psychoactive Drugs. 2005 Jun; 37(2):119-21. de Rios MD, Grob CS. PMID: 16149322.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    25. Ayahuasca in adolescence: Qaualitative results. J Psychoactive Drugs. 2005 Jun; 37(2):135-9. de Rios MD, Grob CS, Lopez E, da Silviera DX, Alonso LK, Doering-Silveira E. PMID: 16149325.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    26. Ayahuasca in adolescence: a preliminary psychiatric assessment. J Psychoactive Drugs. 2005 Jun; 37(2):129-33. Da Silveira DX, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, Doering-Silveira E. PMID: 16149324.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    27. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry. 2005 May 01; 57(9):967-74. Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T. PMID: 15860336; PMCID: PMC4899039.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    28. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005 Feb; 162(2):361-9. Chang L, Ernst T, Speck O, Grob CS. PMID: 15677602; PMCID: PMC4899042.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    29. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol. 2003 Nov; 17(4):446-59. Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE. PMID: 15168910.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    30. Hallucinogens and redemption. J Psychoactive Drugs. 2002 Jul-Sep; 34(3):239-48. de Rios MD, Grob CS, Baker JR. PMID: 12422934.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    31. The politics of Ecstasy. J Psychoactive Drugs. 2002 Apr-Jun; 34(2):143-4. Grob CS. PMID: 12691204.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    Charles's Networks
    Concepts (149)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California